BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 17686827)

  • 1. Epigenetic specificity of loss of imprinting of the IGF2 gene in Wilms tumors.
    Bjornsson HT; Brown LJ; Fallin MD; Rongione MA; Bibikova M; Wickham E; Fan JB; Feinberg AP
    J Natl Cancer Inst; 2007 Aug; 99(16):1270-3. PubMed ID: 17686827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of imprinting of insulin-like growth factor-II (IGF2) gene in distinguishing specific biologic subtypes of Wilms tumor.
    Ravenel JD; Broman KW; Perlman EJ; Niemitz EL; Jayawardena TM; Bell DW; Haber DA; Uejima H; Feinberg AP
    J Natl Cancer Inst; 2001 Nov; 93(22):1698-703. PubMed ID: 11717330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of imprinting of insulin-like growth factor-II in Wilms' tumor commonly involves altered methylation but not mutations of CTCF or its binding site.
    Cui H; Niemitz EL; Ravenel JD; Onyango P; Brandenburg SA; Lobanenkov VV; Feinberg AP
    Cancer Res; 2001 Jul; 61(13):4947-50. PubMed ID: 11431321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of chromosome arm 16q loss with loss of imprinting of insulin-like growth factor-II in Wilms tumor.
    Mummert SK; Lobanenkov VA; Feinberg AP
    Genes Chromosomes Cancer; 2005 Jun; 43(2):155-61. PubMed ID: 15761865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic alteration at the DLK1-GTL2 imprinted domain in human neoplasia: analysis of neuroblastoma, phaeochromocytoma and Wilms' tumour.
    Astuti D; Latif F; Wagner K; Gentle D; Cooper WN; Catchpoole D; Grundy R; Ferguson-Smith AC; Maher ER
    Br J Cancer; 2005 Apr; 92(8):1574-80. PubMed ID: 15798773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of imprinting of IGF2 is linked to reduced expression and abnormal methylation of H19 in Wilms' tumour.
    Steenman MJ; Rainier S; Dobry CJ; Grundy P; Horon IL; Feinberg AP
    Nat Genet; 1994 Jul; 7(3):433-9. PubMed ID: 7920665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relaxation of IGF2 imprinting in Wilms tumours associated with specific changes in IGF2 methylation.
    Sullivan MJ; Taniguchi T; Jhee A; Kerr N; Reeve AE
    Oncogene; 1999 Dec; 18(52):7527-34. PubMed ID: 10602511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic differences between Wilms' tumours in white and east-Asian children.
    Fukuzawa R; Breslow NE; Morison IM; Dwyer P; Kusafuka T; Kobayashi Y; Becroft DM; Beckwith JB; Perlman EJ; Reeve AE
    Lancet; 2004 Feb; 363(9407):446-51. PubMed ID: 14962525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic changes encompassing the IGF2/H19 locus associated with relaxation of IGF2 imprinting and silencing of H19 in Wilms tumor.
    Taniguchi T; Sullivan MJ; Ogawa O; Reeve AE
    Proc Natl Acad Sci U S A; 1995 Mar; 92(6):2159-63. PubMed ID: 7534414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered expression of imprinted genes in Wilms tumors.
    Hubertus J; Lacher M; Rottenkolber M; Müller-Höcker J; Berger M; Stehr M; von Schweinitz D; Kappler R
    Oncol Rep; 2011 Mar; 25(3):817-23. PubMed ID: 21174059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency and timing of loss of imprinting at 11p13 and 11p15 in Wilms' tumor development.
    Brown KW; Power F; Moore B; Charles AK; Malik KT
    Mol Cancer Res; 2008 Jul; 6(7):1114-23. PubMed ID: 18644976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in the promoter-specific imprinting of the insulin-like growth factor-II gene in Wilms' tumor.
    Vu TH; Hoffman A
    J Biol Chem; 1996 Apr; 271(15):9014-23. PubMed ID: 8621549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global demethylation in loss of imprinting subtype of Wilms tumor.
    Ludgate JL; Le Mée G; Fukuzawa R; Rodger EJ; Weeks RJ; Reeve AE; Morison IM
    Genes Chromosomes Cancer; 2013 Feb; 52(2):174-84. PubMed ID: 23074036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of Igf2 imprinting in monoclonal mouse hepatic tumor cells is not associated with abnormal methylation patterns for the H19, Igf2, and Kvlqt1 differentially methylated regions.
    Ishizaki T; Yoshie M; Yaginuma Y; Tanaka T; Ogawa K
    J Biol Chem; 2003 Feb; 278(8):6222-8. PubMed ID: 12475990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive methylation analysis of imprinting-associated differentially methylated regions in colorectal cancer.
    Hidaka H; Higashimoto K; Aoki S; Mishima H; Hayashida C; Maeda T; Koga Y; Yatsuki H; Joh K; Noshiro H; Iwakiri R; Kawaguchi A; Yoshiura KI; Fujimoto K; Soejima H
    Clin Epigenetics; 2018 Dec; 10(1):150. PubMed ID: 30509319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of imprinting of a paternally expressed transcript, with antisense orientation to KVLQT1, occurs frequently in Beckwith-Wiedemann syndrome and is independent of insulin-like growth factor II imprinting.
    Lee MP; DeBaun MR; Mitsuya K; Galonek HL; Brandenburg S; Oshimura M; Feinberg AP
    Proc Natl Acad Sci U S A; 1999 Apr; 96(9):5203-8. PubMed ID: 10220444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wilms tumour histology is determined by distinct types of precursor lesions and not epigenetic changes.
    Fukuzawa R; Anaka MR; Heathcott RW; McNoe LA; Morison IM; Perlman EJ; Reeve AE
    J Pathol; 2008 Aug; 215(4):377-87. PubMed ID: 18484682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent IGF2/H19 domain epigenetic alterations and elevated IGF2 expression in epithelial ovarian cancer.
    Murphy SK; Huang Z; Wen Y; Spillman MA; Whitaker RS; Simel LR; Nichols TD; Marks JR; Berchuck A
    Mol Cancer Res; 2006 Apr; 4(4):283-92. PubMed ID: 16603642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequent loss of imprinting of the H19 gene is often associated with its overexpression in human lung cancers.
    Kondo M; Suzuki H; Ueda R; Osada H; Takagi K; Takahashi T; Takahashi T
    Oncogene; 1995 Mar; 10(6):1193-8. PubMed ID: 7700644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of imprinting of IGF2 sense and antisense transcripts in Wilms' tumor.
    Vu TH; Chuyen NV; Li T; Hoffman AR
    Cancer Res; 2003 Apr; 63(8):1900-5. PubMed ID: 12702581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.